MyFinsight
Home
Blog
About
Proceeds from labcorp
sale
$18,392K
Proceeds from the sale of
property, plant and...
$148K
(-18.23%↓ Y/Y)
Net cash (used in)
provided by investing...
$15,536K
(-58.78%↓ Y/Y)
Canceled cashflow
$3,004K
Net (decrease)
increase in cash, cash...
-$41,135K
(74.33%↑ Y/Y)
Canceled cashflow
$15,536K
Depreciation and
amortization
$22,408K
(-51.83%↓ Y/Y)
Accounts payable
$5,369K
(-33.61%↓ Y/Y)
Inventory, net
-$2,842K
(-148.05%↓ Y/Y)
Non-cash interest
$2,550K
(-95.86%↓ Y/Y)
Equity-based compensation
employees and...
$2,238K
(-53.65%↓ Y/Y)
Realized gain on disposal
of fixed assets and...
-$149K
(-103.86%↓ Y/Y)
Amortization of deferred
financing costs
$138K
(-97.22%↓ Y/Y)
Foreign currency
measurement
$136K
(106.84%↑ Y/Y)
Borrowings on lines of
credit
$10,178K
(-38.82%↓ Y/Y)
Capital expenditures
$3,004K
(-53.62%↓ Y/Y)
Net cash used in
operating activities
-$43,500K
(63.13%↑ Y/Y)
Canceled cashflow
$35,830K
Net cash used in
financing activities
-$13,026K
(84.40%↑ Y/Y)
Effect of exchange rate
changes on cash, cash...
-$145K
(-104.06%↓ Y/Y)
Canceled cashflow
$10,178K
Revenue from the receipt
of equity
$27,269K
Gain on sale of assets
$18,070K
Net loss
-$8,416K
(96.10%↑ Y/Y)
Accrued expenses and
other liabilities
-$8,310K
(80.96%↑ Y/Y)
Deferred income tax
(benefit) provision
-$6,265K
(72.92%↑ Y/Y)
Other current assets
and prepaid...
$6,087K
(162.60%↑ Y/Y)
Accounts receivable, net
$2,388K
(112.49%↑ Y/Y)
Change in fair value of
equity securities and...
$2,353K
(235.70%↑ Y/Y)
Other assets
$172K
(-66.27%↓ Y/Y)
Share repurchase
$13,020K
(-28.68%↓ Y/Y)
Repayments of lines of
credit
$9,845K
(-49.22%↓ Y/Y)
Proceeds from the
exercise of common stock...
-$339K
(-175.61%↓ Y/Y)
Back
Back
Cash Flow
OPKO HEALTH, INC. (OPK)
OPKO HEALTH, INC. (OPK)
source: myfinsight.com